Doltendix® | Dietary supplement for tendons and ligaments — Kolinpharma
ES EN
Kolinpharma® · Leader to Health

Specialized nutrition for tendons and ligaments.

Doltendix® combines tendon-specific bioactive collagen peptides, astaxanthin, trans-resveratrol and vitamin C: a nutritional supplement formula developed with selected ingredients backed by scientific research. The highest dose of specific collagen available on the market.

Patented in Italy and China Ingredients with published research ISO 9001 · 14001 · 22000
Person holding their knee — Doltendix for tendons and ligaments Doltendix — product box, 20 sachets of 5 g
0 mg
TENDOFORTE® collagen
0 mg
AstaReal® astaxanthin
0 mg
Vitamin C (625% NRV)
0 mg
Veri·Sperse® trans-resveratrol
0
5 g sachets per box
The product

Every detail, up close

A powdered dietary supplement in single-dose sachets, easy to measure and add to your daily routine.

Who it is for

Nutrition and care for tendons and ligaments

Designed for people who want to complement their daily diet with bioactive collagen peptides, in routines with high physical demands and everyday movement.

Active person training
Active person in motion
Physical and sports demands
Everyday activity and movement
Demanding training routines
Active lifestyle
Need to complement daily nutrition
The formula

Developed with nutrients and selected ingredients

Specific collagen
Tendon and ligament structure
Antioxidants
4 actives in one formula
The formulation

A combination of selected ingredients

Doltendix® was developed with a specific combination of bioactive collagen peptides and selected micronutrients, brought together in a single daily dose to complement the nutrition of tendons and ligaments.

Scientific evidence

Studied in experimental models

In an in vitro study on human tenocytes (tendon cells), the formulation was evaluated against different biomarkers associated with inflammatory processes (IL-1β) and oxidative stress (reactive oxygen species, ROS).

Source: Mediators of Inflammation, Impact Factor 4.4 — 2024 Jul 30:2024:5273198. doi: 10.1155/2024/5273198.

In vitro study — human tenocytes
IL-1β
Inflammatory marker
STUDY
ROS
Oxidative stress
Why choose Doltendix

For tendons and ligaments

Composition

Research on specific collagen

The formula’s bioactive collagen peptides were studied in relation to the collagen composition of tendons and ligaments, in research models.

ModelType III collagen — “rigid structure”
ResearchType I collagen — “elastic structure”
The highest dose

Of specific collagen (bioactive peptides) available on the market

With 5000 mg of TENDOFORTE® collagen per daily dose, Doltendix® far exceeds the concentration of other comparable supplements on the market.

Comparison of specific collagen dose in mg: Doltendix versus other products on the market (A-E)
Composition

Four actives, one synergy

Each Doltendix® ingredient has a specific role and its own scientific backing, brought together in a single formula with published research on tendons and ligaments.

5000 mg

Bioactive collagen peptides

TENDOFORTE®
  • High absorption and bioavailability
  • High tendon specificity (optimal molecular weight of 2000 g/mol)
  • Studied in research for their relationship with type I collagen synthesis
8 mg

Astaxanthin

AstaReal®
  • Studied for its activity on macrophages in scientific research
  • Evaluated in relation to type I/III collagen in preclinical models
  • Studied in preclinical models of tendon tensile strength
150 mg

Trans-resveratrol

Veri·Sperse®
  • Studied on human tenocytes in in vitro research
  • Evaluated for its relationship with microcirculation in experimental studies
  • 3 times the bioavailability of standard trans-resveratrol
500 mg

Vitamin C

625% NRV
  • Contributes to normal collagen formation*
  • Studied in relation to tissue repair processes in experimental research
  • Evaluated in experimental models of connective tissue

*Health claim subject to verification of current authorization by ANMAT.

The scientific basis

Clinical and preclinical evidence

The results of Doltendix® and each of its actives are backed by in vitro, preclinical and clinical studies.

In vitro study — full Doltendix® formula+
Human tenocytes · Anti-inflammatory and antioxidant properties of a new mixture of vitamin C, collagen peptides, resveratrol and astaxanthin in tenocytes

In the in vitro study, the combination of vitamin C, collagen peptides, trans-resveratrol and astaxanthin showed differences compared with each active substance evaluated separately, with a significant reduction of IL-6 and MMP-2 in the cell model.

Anti-inflammatory action · in vitro study on human tenocytes
IL-60.00.51.01.5IL-6 (fold change vs IL-1β)IL-1βVit CCollResvAsxDoltendix®*********
MMP-2012MMP-2 (fold change vs IL-1β)IL-1βVit CCollResvAsxDoltendix®*******
IL-1β: cells stimulated with IL-1β (control) · Vit C: vitamin C · Coll: collagen peptides · Resv: trans-resveratrol · Asx: astaxanthin — *p<0.05 · **p<0.01 · ***p<0.001 · ****p<0.0001

The same study also recorded a significant reduction of reactive oxygen species (ROS) in the cell model.

Antioxidant action · in vitro study on human tenocytes
ROS vs control01234ROS (fold induction vs control)ControlH₂O₂Doltendix®H₂O₂ +Doltendix®***
ROS vs H₂O₂0.00.51.01.5ROS (fold induction vs H₂O₂)H₂O₂Vit CCollResvAsxDoltendix®********
*p<0.05 · **p<0.01 · ***p<0.001 · ****p<0.0001
Real-life study — 150 patients with epicondylitis+
150 patients · 2 sachets/day for 10 days, 1 sachet/day for 20 days

Participants were assessed with the VAS scale (pain) and the Quick-DASH index (disability), comparing baseline values with those recorded at the 30-day follow-up.

Real-life study · 150 patients with epicondylitis
Pain02468VAS (10 cm)Before intakeT0***After 10 daysT1*** ###After 30 daysT2
Disability index0204060Quick-DASH (%)Before intakeT0***After 10 daysT1*** ###After 30 daysT2
Regimen: 2 sachets/day for 10 days and 1 sachet/day for 20 days.
Full results available in the corresponding scientific publication.
Combination with physiotherapy+
QuickDash score over time — Doltendix® alone vs. combined with physiotherapy

The study evaluated the QuickDash score over time in two groups: one taking the Doltendix® formulation alone and another combining it with physiotherapy.

QuickDash score · Doltendix® with and without physiotherapy
010203040506070QuickDash scoreT0T1T2
Doltendix® + physiotherapy (65%)Doltendix® alone (35%)
TENDOFORTE® — athletes with Achilles tendinopathy+
20 athletes · Double-blind, randomized, placebo-controlled clinical study · Journal of Sports Science and Medicine, 2018

Both groups performed eccentric exercises throughout the study. The group that received Tendoforte® showed differences compared with the group that performed eccentric exercises only, according to the scales assessed in the research protocol, both during the study and at the 3-month follow-up.

TENDOFORTE® · athletes with Achilles tendinopathy
VISA-A406080100VISA-AT1baselineT23 monthsT36 months******
Return to running0246810No. of participants63T23 months75T36 months
Group AGroup B
*p<0.05
TENDOFORTE® — athletes with chronic ankle instability+
50 athletes · Double-blind, randomized, placebo-controlled clinical study · 5 g/day for 6 months

Assessment using the CAIT (perceived instability and pain, 0–30) and FAAM-G (functional assessment of ankle and foot, 0–100) scales.

ScaleGroupBaseline (T0)6 months (T1)p-value
CAITTendoforte®15.4820.76<0.05
CAITPlacebo20.8021.45—
FAAM-G ADL (%)Tendoforte®81.5691.32<0.05
FAAM-G ADL (%)Placebo90.2891.44—
FAAM-G Sport (%)Tendoforte®60.4880.36<0.05
FAAM-G Sport (%)Placebo76.2476.52—

3-month follow-up — reduction in ankle sprains: 24/25 in the Tendoforte® group versus 9/25 in the placebo group (p<0.001).

Astaxanthin — anti-inflammatory action and effect on collagen+
Eur J Nutr, 2010 · Preclinical model in adult rabbits

Astaxanthin suppresses the expression of scavenger receptors and the activity of matrix metalloproteinases (MMP) in macrophages, reducing TNF-α, IL-1β, IL-6 and COX-2.

Astaxanthin in macrophages · expression relative to β-actin
TNF-α0.00.51.01.5TNF-α/β-actin00**5**10monocytesmacrophages
IL-1β0.00.51.01.52.0IL-1β/β-actin00***5***10monocytesmacrophages
IL-60246IL-6/β-actin (×10⁻⁵)00***5***10monocytesmacrophages
COX-20.000.050.100.150.20COX-2/β-actin00***5***10monocytesmacrophages
MMP-20.00.20.40.60.8MMP-2/β-actin005*10monocytesmacrophages
MMP-90510152025MMP-9/β-actin00***5***10monocytesmacrophages
astaxanthin (µM) — *p<0.05 · **p<0.01 · ***p<0.001 · ****p<0.0001

In a preclinical model with 32 adult rabbits (4 mg/day for 3 weeks), astaxanthin increases tendon tensile strength and decreases type III collagen production in favor of type I collagen.

Astaxanthin · preclinical model in adult rabbits
Tendon tensile strength888990919293Tensile strength92.6Astaxanthin (+)88.5Astaxanthin (−)
Type III/I collagen ratio100020003000400050006000Collagen III/IAstaxanthin (+)Astaxanthin (−)
Veri·Sperse® trans-resveratrol — bioavailability+
Comparative bioavailability study · Patented LipiSperse® technology

Thanks to its patented dispersion technology, Veri·Sperse® trans-resveratrol achieves a water suspension capacity about 6,000 times higher than standard trans-resveratrol. Its bioavailability is three times higher than that of standard trans-resveratrol administered at the same concentration.

Plasma concentration of trans-resveratrol
01000200030004000Plasma concentration (ng/ml)024681012Time (h)
150 mg Veri·Sperse®75 mg Veri·Sperse®150 mg standard trans-resveratrol
Bioactive collagen peptides — presence in tissue+
Ex vivo preclinical model

14C-labeled bioactive collagen peptides show high absorption and a greater affinity for connective tissue than free proline, with sustained presence up to 192 hours — supporting the synthesis of new type I collagen, essential for tendon function.

Bioactive collagen peptides · presence in connective tissue (ex vivo model)
0204060Bq/g of tissue024487296192Time (h)****
[¹⁴C] bioactive collagen peptides[¹⁴C] free proline
How to use

A clear protocol, in two phases

Preparing a Doltendix sachet in water
2 sachetsa day, for 10 days
1 sacheta day, for 20 days

A dietary supplement designed to support the daily nutrition of tendons and ligaments, at any stage of your routine.

Everyday activity
Training routine
Daily nutrition
Ongoing supplementation

One formula, four components

TENDOFORTE® — 5,000 mg of bioactive collagen peptides
AstaReal® — 8 mg of astaxanthin
Veri·Sperse® — 150 mg of trans-resveratrol
Vitamin C — 500 mg (625% NRV)
The science behind Doltendix®

From the formula to published research

Four selected ingredients, combined in a single formula and backed by published experimental and clinical studies.

Formulation
  • Bioactive collagen peptides
  • Astaxanthin
  • Trans-resveratrol
  • Vitamin C
4 selected ingredients
Scientific research
  • In vitro studies
  • Preclinical models
  • Clinical studies
Published results
Daily supplementation
  • 2 sachets/day × 10 days
  • 1 sachet/day × 20 days
Recommended use
Quality and commitment

Kolinpharma® guarantees high quality standards

Kolinpharma® applies high quality standards, from formulation to the marketing of its nutraceutical solutions.

ISO 22000

Guarantee of food hygiene and safety in the agri-food sector.

ISO 14001

Monitoring of activities with a significant environmental impact.

ISO 9001

Standards for quality management systems.

Jewish and Muslim doctrines

High quality standards in line with both religious doctrines.

Not on the WADA list

Free of substances on the World Anti-Doping Agency list.

Anti-counterfeiting system

Tamper-evident opening to guarantee product integrity.

Low vision

Packaging designed with people with low vision in mind.

Gluten- and lactose-free

Formulated to ensure safety and closeness to the consumer.

Patent

A unique and innovative product

🇮🇹 Patented in Italy 🇨🇳 Patented in China

Title registered in the patent application:

“Composition useful for the treatment of tendinopathies”

Technical title registered in the patent application; it does not constitute an authorized therapeutic indication for marketing the product as a dietary supplement.

Frequently asked questions

Everything you need to know

What is Doltendix®?+

It is a dietary supplement formulated by Kolinpharma® that combines tendon-specific bioactive collagen peptides (TENDOFORTE®), astaxanthin (AstaReal®), trans-resveratrol (Veri·Sperse®) and vitamin C, designed to complement the nutrition of tendons and ligaments.

How do I take it?+

The usual protocol is 2 sachets a day for 10 days, followed by 1 sachet a day for 20 days. Each sachet contains 5 g, with sweetener.

What sets Doltendix® apart from other collagen supplements?+

It provides 5000 mg of specific collagen (bioactive peptides) per daily dose — the highest concentration available on the market according to the comparison published by Kolinpharma® — combined with astaxanthin, trans-resveratrol and vitamin C in a patented formula.

Is it backed by clinical studies?+

Yes. The full formula has an in vitro study on human tenocytes and a real-life study in 150 patients with epicondylitis. In addition, its active ingredients (TENDOFORTE®, astaxanthin, trans-resveratrol and vitamin C) have their own studies, including two double-blind clinical trials with athletes.

Is it patented?+

Yes, Doltendix® is patented in Italy and China. The patent application registers the composition under the technical title “useful for the treatment of tendinopathies”, a registration title that is not equivalent to an authorized therapeutic indication for marketing it as a dietary supplement.

What quality controls does it have?+

Kolinpharma® certifies its processes under ISO 9001, ISO 14001 and ISO 22000, and the product meets standards in line with Jewish and Muslim doctrines, contains no substances on the WADA list, has a tamper-evident opening system, is designed with people with low vision in mind, and is gluten- and lactose-free.

Daily supplementation for tendons and ligaments

Tendon-specific collagen at its highest dose, astaxanthin, trans-resveratrol and vitamin C — a dietary supplement backed by scientific evidence and patented in Italy and China.

Patented in Italy and China · Kolinpharma® · Manufactured under ISO 9001 · 14001 · 22000
0
0
Your Cart
Empty CartYour cart is emptyBack to shop
Scroll to Top